Shift from high-frequency to low-frequency episodic migraine in patients treated with Galcanezumab: results from two global randomized clinical trials

BACKGROUND: Patients with episodic migraine (EM) with a higher-frequency of migraine headache days (HFEM: 8–14 migraine headache days/month) have a greater disease burden and a higher risk of progressing to chronic migraine (CM) with associated acute treatment overuse versus those with low-frequency...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Headache Pain
Egile Nagusiak: Jedynak, Jakub, Eross, Eric, Gendolla, Astrid, Rettiganti, Mallikarjuna, Stauffer, Virginia L.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer Milan 2021
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8161994/
https://ncbi.nlm.nih.gov/pubmed/34049484
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s10194-021-01222-w
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak